TY - JOUR
T1 - Role of 18-hydroxylated cortisols in hypertension
AU - Gomez-Sanchez, Celso E.
AU - Gomez-Sanchez, elise P.
AU - Holland, O. Bryan
N1 - Funding Information:
Acknowledgemen&-Thee xpertt echnicalh elp of Mark F. Foecking, Robert J. Upcavagea nd Melinda Lake is gratefully acknowledgedT. hese studiesw ere supportedi n part by Medical Research Funds from the Veterans Administration,N IH grants (HL 27255a nd 26856)a nd by grantR R-73 from the GeneralC linical ResearchC enters Programo f the Division of ResearchR esources,N IH.
PY - 1987
Y1 - 1987
N2 - The isolation of 18-hydroxycortisol and 18-oxocortisol was recently described. These steroids have been shown to be excreted in exaggerated quantities in patients with primary aldosteronism, with adrenal adenomas and in glucocorticoid suppressible aldosteronism. We report the measurement of both steroids in the urine of patients with essential hypertension. 18-Oxocortisol excretion did not differ in patients with normal renin essential hypertension (0.7 ± 0.7 μg/24 h), low renine essential hypertension (0.7 ± 0.5 μg/24 h) and normal individuals (1.2 ±0.9 μg/24 h). Patients with normal renin hypertension excreted 54 ± 43 μg/24 h of 18-hydroxycortisol, those with low renin essential hypertension excreted 58 ± 54 μg/24 h, and normal individuals excreted 63 ± 36 βg/24 h. Three of the low renin and one of the normal renin hypertensive subjects excreted greater quantities of 18-hydroxycortisol than the upper limit of normal, but all excreted normal quantities of 18-oxocortisol. As 18-hydroxycortisol is inactive, the meaning of this elevated excretion is unclear, but it may be a marker of an adrenal enzymatic abnormality which may be playing a more direct role in hypertension.
AB - The isolation of 18-hydroxycortisol and 18-oxocortisol was recently described. These steroids have been shown to be excreted in exaggerated quantities in patients with primary aldosteronism, with adrenal adenomas and in glucocorticoid suppressible aldosteronism. We report the measurement of both steroids in the urine of patients with essential hypertension. 18-Oxocortisol excretion did not differ in patients with normal renin essential hypertension (0.7 ± 0.7 μg/24 h), low renine essential hypertension (0.7 ± 0.5 μg/24 h) and normal individuals (1.2 ±0.9 μg/24 h). Patients with normal renin hypertension excreted 54 ± 43 μg/24 h of 18-hydroxycortisol, those with low renin essential hypertension excreted 58 ± 54 μg/24 h, and normal individuals excreted 63 ± 36 βg/24 h. Three of the low renin and one of the normal renin hypertensive subjects excreted greater quantities of 18-hydroxycortisol than the upper limit of normal, but all excreted normal quantities of 18-oxocortisol. As 18-hydroxycortisol is inactive, the meaning of this elevated excretion is unclear, but it may be a marker of an adrenal enzymatic abnormality which may be playing a more direct role in hypertension.
UR - http://www.scopus.com/inward/record.url?scp=0023622694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023622694&partnerID=8YFLogxK
U2 - 10.1016/0022-4731(87)90176-2
DO - 10.1016/0022-4731(87)90176-2
M3 - Article
C2 - 3320570
AN - SCOPUS:0023622694
SN - 0022-4731
VL - 27
SP - 971
EP - 975
JO - Journal of Steroid Biochemistry
JF - Journal of Steroid Biochemistry
IS - 4-6
ER -